NeueHealth (NEUE) Projected to Post Quarterly Earnings on Thursday

NeueHealth (NYSE:NEUEGet Free Report) is projected to release its earnings data before the market opens on Thursday, March 20th. Analysts expect NeueHealth to post earnings of ($2.29) per share and revenue of $261.80 million for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

NeueHealth Trading Down 7.4 %

NYSE:NEUE opened at $4.71 on Tuesday. The firm has a market capitalization of $38.98 million, a price-to-earnings ratio of -0.09 and a beta of 0.56. The firm’s fifty day simple moving average is $7.21 and its 200 day simple moving average is $6.01. NeueHealth has a twelve month low of $3.79 and a twelve month high of $7.66.

Insider Transactions at NeueHealth

In other NeueHealth news, CFO Jay Matushak sold 4,448 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the sale, the chief financial officer now directly owns 41,592 shares in the company, valued at $280,330.08. This represents a 9.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO George Lawrence Mikan III sold 12,440 shares of the company’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $6.13, for a total value of $76,257.20. Following the completion of the sale, the chief executive officer now owns 249,454 shares of the company’s stock, valued at approximately $1,529,153.02. This trade represents a 4.75 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 110,033 shares of company stock valued at $774,560. Insiders own 64.30% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada cut their price objective on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a report on Monday, December 9th.

View Our Latest Research Report on NEUE

NeueHealth Company Profile

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Featured Stories

Earnings History for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.